SUMMIT, NJ - Merck today announced plans to move its global headquarters from Whitehouse Station to its existing facilities in Kenilworth. The company had previously announced that it would close its Whitehouse Station building and relocate its global headquarters to Summit, however, after re-evaluating its real estate needs in the state, Merck determined that it could achieve greater cost savings and operational synergies by closing both its Summit campus and its main Whitehouse Station facility. The transition is expected to begin next year and be completed by 2015.
"From our perspective, it is obviously disappointing that Merck has decided to consolidate its operations to the Kenilworth campus," said Summit Mayor Ellen Dickson. "The impact of Merck leaving will be felt throughout Summit. The company has been a good neighbor and contributed positively to the community"
Dickson continued, saying, "The Summit campus is a highly desirable location, and never stays available for long. We are optimistic that Merck's departure will be another company's gain."
Merck's updated plans are part of the company’s global initiative announced today, which will see 8,500 jobs cut, and is designed to sharpen its commercial and research & development focus, and reduce costs, including the size of its work force and global real estate footprint. Merck’s Animal Health and Consumer Care divisions, currently located in Summit, will be relocated to another facility in New Jersey. In addition, certain manufacturing, laboratory and other functions currently located in Summit will be relocated to other facilities in New Jersey or Pennsylvania.
Merck has been headquartered in Whitehouse Station since 1992. Prior to 1992, the company was headquartered in Rahway.